183 related articles for article (PubMed ID: 34805271)
21. Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a FOXO3/miRNA-30b-5p/MINPP1 axis.
Chen W; Jiang J; Gong L; Shu Z; Xiang D; Zhang X; Bi K; Diao H
J Exp Clin Cancer Res; 2021 Jan; 40(1):1. PubMed ID: 33390177
[TBL] [Abstract][Full Text] [Related]
22. Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation.
Chen P; Luo X; Dai G; Jiang Y; Luo Y; Peng S; Wang H; Xie P; Qu C; Lin W; Hong J; Ning X; Li A
Exp Mol Med; 2020 Jul; 52(7):1062-1074. PubMed ID: 32632241
[TBL] [Abstract][Full Text] [Related]
23. Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells.
Ji Y; Wang Z; Chen H; Zhang L; Zhuo F; Yang Q
Cell Physiol Biochem; 2018; 47(1):39-53. PubMed ID: 29763915
[TBL] [Abstract][Full Text] [Related]
24. Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+ Immune Cells.
Kondo Y; Kimura O; Tanaka Y; Ninomiya M; Iwata T; Kogure T; Inoue J; Sugiyama M; Morosawa T; Fujisaka Y; Shimosegawa T
J Virol; 2015 Jul; 89(14):7016-27. PubMed ID: 25926643
[TBL] [Abstract][Full Text] [Related]
25. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J
Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696
[TBL] [Abstract][Full Text] [Related]
26. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression.
Zhao Q; Li T; Qi J; Liu J; Qin C
PLoS One; 2014; 9(10):e109782. PubMed ID: 25299640
[TBL] [Abstract][Full Text] [Related]
27. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
28. HBx-induced MiR-1269b in NF-κB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells.
Kong XX; Lv YR; Shao LP; Nong XY; Zhang GL; Zhang Y; Fan HX; Liu M; Li X; Tang H
J Transl Med; 2016 Jun; 14(1):189. PubMed ID: 27349221
[TBL] [Abstract][Full Text] [Related]
29. DTNA promotes HBV-induced hepatocellular carcinoma progression by activating STAT3 and regulating TGFβ1 and P53 signaling.
Hu ZG; Zhang S; Chen YB; Cao W; Zhou ZY; Zhang JN; Gao G; He SQ
Life Sci; 2020 Oct; 258():118029. PubMed ID: 32619495
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway.
Bai PS; Hou P; Kong Y
Exp Cell Res; 2018 Sep; 370(1):174-188. PubMed ID: 29928866
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus promotes hepatocellular carcinoma development by activating GP73 to repress the innate immune response.
Liu L; Huang Y; Fu Y; Rao J; Zeng F; Ji M; Xu X; Zhu J; Du W; Liu Z
Infect Agent Cancer; 2022 Oct; 17(1):52. PubMed ID: 36195933
[TBL] [Abstract][Full Text] [Related]
32. TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression.
Yang J; Zhang L; Jiang Z; Ge C; Zhao F; Jiang J; Tian H; Chen T; Xie H; Cui Y; Yao M; Li H; Li J
Theranostics; 2019; 9(20):5810-5827. PubMed ID: 31534521
[TBL] [Abstract][Full Text] [Related]
33. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
34. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B Virus Core Protein Mediates the Upregulation of C5α Receptor 1 via NF-κB Pathway to Facilitate the Growth and Migration of Hepatoma Cells.
Kong F; Tao Y; Yuan D; Zhang N; Li Q; Yu T; Yang X; Kong D; Ding X; Liu X; You H; Zheng K; Tang R
Cancer Res Treat; 2021 Apr; 53(2):506-527. PubMed ID: 33197304
[TBL] [Abstract][Full Text] [Related]
36. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
37. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
38. Tissue transglutaminase 2 exerts a tumor-promoting role in hepatitis B virus-related hepatocellular carcinoma.
Yu C; Cao Q; Chen P; Yang S; Gong X; Deng M; Ruan B; Li L
Tumour Biol; 2016 Oct; ():. PubMed ID: 27783362
[TBL] [Abstract][Full Text] [Related]
39. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
40. Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signaling.
Wu S; Ye S; Lin X; Chen Y; Zhang Y; Jing Z; Liu W; Chen W; Lin X; Lin X
Cancer Lett; 2021 Feb; 499():175-187. PubMed ID: 33249195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
